Transcutaneous microsphere vaccine technology

经皮微球疫苗技术

• 批准号: 269670
• 负责人: Dutz Jan P
• 金额: $ 21.86万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-10-01 至 2015-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=269670&lang=en
• 关键词: Adjuvant; Biomedical Engineering 1900; Drug Delivery; Human Pharmaceuticals 504; Life Sciences 1200; Life Sciences Research 6400; Microneedles; Microspheres; Nanoparticles; Skin

Common "killed" microbe vaccines such as hepatitis vaccine, must be given repeatedly to be effective. Influenza vaccine must be given yearly. This is costly and inconvenient. In recent work we have shown that vaccines can be incorporated into dissolving s

常见的“灭活”微生物疫苗，如肝炎疫苗，必须反复注射才能有效。流感疫苗必须每年注射一次。这既昂贵又不方便。在最近的工作中，我们已经证明，疫苗可以并入溶解的液体中